Arvinas
ARVN • NASDAQ
Arvinas is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Randy Teel, with a market cap of $714.4M.
Market Cap$714.4M
Employees445.0
CEORandy Teel
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Arvinas FAQ
Common questions about Arvinas
Arvinas is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $17.1M.
Arvinas has approximately 445 employees.